VIENNA, May 5, 2026 /PRNewswire/ -- Elaris FlexCo ("Elaris"), an Austrian biotechnology company developing vaccines against serious bacterial infections, today announced that it has entered into an asset purchase agreement with Matrivax Research & Development Corporation ("Matrivax"), a U....
2026 Copyright © News-Matic.com. All Rights Reserved
